Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Liliana Grigorievna Bordeianou, M.D.

Co-Author

This page shows the publications co-authored by Liliana Bordeianou and David Berger.
Connection Strength

9.249
  1. Truth in Reporting: How Data Capture Methods Obfuscate Actual Surgical Site Infection Rates within a Health Care Network System. Dis Colon Rectum. 2017 Jan; 60(1):96-106.
    View in: PubMed
    Score: 0.712
  2. The time Interval Between the End of Radiotherapy and Surgery Does Not Affect Outcomes in Rectal Cancer. Am Surg. 2021 Oct 11; 31348211047215.
    View in: PubMed
    Score: 0.248
  3. Prognosis of Different Histological Types in Patients with Stage II and III Colon Cancer. J Gastrointest Surg. 2021 Sep 09.
    View in: PubMed
    Score: 0.246
  4. Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon Adenocarcinoma. Ann Surg Oncol. 2021 Jun; 28(6):3408-3414.
    View in: PubMed
    Score: 0.232
  5. Adjuvant Chemotherapy Benefits on Patients with Extramural Vascular Invasion in Stages II and III Colon Cancer. J Gastrointest Surg. 2021 08; 25(8):2019-2025.
    View in: PubMed
    Score: 0.231
  6. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer. Dis Colon Rectum. 2019 10; 62(10):1212-1221.
    View in: PubMed
    Score: 0.215
  7. Detrimental impact of symptom-detected colorectal cancer. Surg Endosc. 2020 02; 34(2):569-579.
    View in: PubMed
    Score: 0.209
  8. Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes. J Surg Oncol. 2019 May; 119(6):749-757.
    View in: PubMed
    Score: 0.205
  9. Do Stage I Colorectal Cancers with Lymphatic Invasion Require a Different Postoperative Approach? J Gastrointest Surg. 2019 09; 23(9):1884-1892.
    View in: PubMed
    Score: 0.203
  10. The Impact of a Multivisceral Resection and Adjuvant Therapy in Locally Advanced Colon Cancer. J Gastrointest Surg. 2019 02; 23(2):357-366.
    View in: PubMed
    Score: 0.201
  11. A Transverse Colectomy is as Safe as an Extended Right or Left Colectomy for Mid-Transverse Colon Cancer. World J Surg. 2018 10; 42(10):3381-3389.
    View in: PubMed
    Score: 0.201
  12. Is There a Drawback of Converting a Laparoscopic Colectomy in Colon Cancer? J Surg Res. 2018 12; 232:595-604.
    View in: PubMed
    Score: 0.199
  13. Addition of a scripted pre-operative patient education module to an existing ERAS pathway further reduces length of stay. Am J Surg. 2018 10; 216(4):652-657.
    View in: PubMed
    Score: 0.198
  14. Pathologic factors are more important than tumor location in long-term survival in colon cancer. Int J Colorectal Dis. 2018 Jun; 33(6):709-717.
    View in: PubMed
    Score: 0.193
  15. The Influence of Screening on Outcomes of Clinically Locally Advanced Rectal Cancer. J Gastrointest Surg. 2018 06; 22(6):1052-1058.
    View in: PubMed
    Score: 0.192
  16. Outcomes of persistent lymph node involvement after neoadjuvant therapy for stage III rectal cancer. Surgery. 2018 04; 163(4):784-788.
    View in: PubMed
    Score: 0.190
  17. Effects of local multivisceral resection for clinically locally advanced rectal cancer on long-term outcomes. J Surg Oncol. 2018 May; 117(6):1323-1329.
    View in: PubMed
    Score: 0.190
  18. The negative impact of understaging rectal cancer patients. Am J Surg. 2018 07; 216(1):93-98.
    View in: PubMed
    Score: 0.189
  19. Rectal Cancer in Patients Under 50 Years of Age. J Gastrointest Surg. 2017 Nov; 21(11):1898-1905.
    View in: PubMed
    Score: 0.186
  20. Risk Stratification for Surgical Site Infections in Colon Cancer. JAMA Surg. 2017 07 01; 152(7):686-690.
    View in: PubMed
    Score: 0.184
  21. Do packed red blood cell transfusions really worsen oncologic outcomes in colon cancer? Surgery. 2017 09; 162(3):586-591.
    View in: PubMed
    Score: 0.183
  22. The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer-a Large Single-Center Experience. J Gastrointest Surg. 2017 07; 21(7):1153-1158.
    View in: PubMed
    Score: 0.181
  23. Risk Stratification in Patients with Stage II Colon Cancer. Ann Surg Oncol. 2016 11; 23(12):3907-3914.
    View in: PubMed
    Score: 0.172
  24. The prognostic value of lymph node ratio in colon cancer is independent of resection length. Am J Surg. 2016 Aug; 212(2):251-7.
    View in: PubMed
    Score: 0.169
  25. Effect of High-Grade Disease on Outcomes of Surgically Treated Colon Cancer. Ann Surg Oncol. 2016 Apr; 23(4):1157-63.
    View in: PubMed
    Score: 0.165
  26. Association of Radial Margin Positivity With Colon Cancer. JAMA Surg. 2015 Sep; 150(9):890-8.
    View in: PubMed
    Score: 0.162
  27. The conundrum of the young colon cancer patient. Surgery. 2015 Dec; 158(6):1696-703.
    View in: PubMed
    Score: 0.162
  28. Does active smoking induce hematogenous metastatic spread in colon cancer? Am J Surg. 2015 Nov; 210(5):930-2.
    View in: PubMed
    Score: 0.161
  29. Variations in Metastasis Site by Primary Location in Colon Cancer. J Gastrointest Surg. 2015 Aug; 19(8):1522-7.
    View in: PubMed
    Score: 0.159
  30. The fate of unscreened women in colon cancer: impact on staging and prognosis. Am J Surg. 2015 Jun; 209(6):927-34.
    View in: PubMed
    Score: 0.156
  31. Renewed assessment of the stapled anastomosis with the increasing role of laparoscopic colectomy for colon cancer. Surg Endosc. 2015 Sep; 29(9):2675-82.
    View in: PubMed
    Score: 0.154
  32. Colon cancer surgery following emergency presentation: effects on admission and stage-adjusted outcomes. Am J Surg. 2015 Feb; 209(2):246-53.
    View in: PubMed
    Score: 0.153
  33. Treatment delay in surgically-treated colon cancer: does it affect outcomes? Ann Surg Oncol. 2014 Nov; 21(12):3909-16.
    View in: PubMed
    Score: 0.149
  34. Wound dehiscence after abdominoperineal resection for low rectal cancer is associated with decreased survival. Dis Colon Rectum. 2014 Feb; 57(2):143-50.
    View in: PubMed
    Score: 0.145
  35. Gender and ethnic disparities in colon cancer presentation and outcomes in a US universal health care setting. J Surg Oncol. 2014 Jun; 109(7):645-51.
    View in: PubMed
    Score: 0.145
  36. Obesity, outcomes and quality of care: body mass index increases the risk of wound-related complications in colon cancer surgery. Am J Surg. 2014 Jan; 207(1):17-23.
    View in: PubMed
    Score: 0.142
  37. Impact of screening colonoscopy on outcomes in colon cancer surgery. JAMA Surg. 2013 Aug; 148(8):747-54.
    View in: PubMed
    Score: 0.140
  38. Preoperative carcinoembryonic antigen as an outcome predictor in colon cancer. J Surg Oncol. 2013 Jul; 108(1):14-8.
    View in: PubMed
    Score: 0.138
  39. The impact of adhesions on operations and postoperative recovery in colon cancer surgery. Am J Surg. 2013 Aug; 206(2):166-71.
    View in: PubMed
    Score: 0.137
  40. Short-term outcomes in obese patients after colectomy for adenocarcinoma at a bariatric center. J Gastrointest Surg. 2012 Oct; 16(10):1923-8.
    View in: PubMed
    Score: 0.131
  41. Sigmoidectomy syndrome? Patients' perspectives on the functional outcomes following surgery for diverticulitis. Dis Colon Rectum. 2012 Jan; 55(1):10-7.
    View in: PubMed
    Score: 0.126
  42. Factors affecting lymph node yield from patients undergoing colectomy for cancer. Int J Colorectal Dis. 2011 Sep; 26(9):1163-8.
    View in: PubMed
    Score: 0.120
  43. Determining the need for radical surgery in patients with T1 rectal cancer. Arch Surg. 2011 May; 146(5):540-3.
    View in: PubMed
    Score: 0.120
  44. The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery. Dis Colon Rectum. 2011 Feb; 54(2):171-5.
    View in: PubMed
    Score: 0.118
  45. Laparoscopy decreases anastomotic leak rate in sigmoid colectomy for diverticulitis. Arch Surg. 2011 Feb; 146(2):207-10.
    View in: PubMed
    Score: 0.118
  46. The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery. Am J Surg. 2010 Oct; 200(4):440-5.
    View in: PubMed
    Score: 0.115
  47. Contained anastomotic leaks after colorectal surgery: are we too slow to act? Arch Surg. 2009 Apr; 144(4):333-8; discussion 338.
    View in: PubMed
    Score: 0.104
  48. The growing trend for no primary surgery in colorectal cancer. Colorectal Dis. 2021 10; 23(10):2659-2670.
    View in: PubMed
    Score: 0.061
  49. The Use of Single-Agent Versus Multiple-Agent Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Rectal Cancer. J Gastrointest Cancer. 2021 Jul 01.
    View in: PubMed
    Score: 0.061
  50. Zip Code-Related Income Disparities in Patients with Colorectal Cancer. Am Surg. 2021 Jun 08; 31348211023435.
    View in: PubMed
    Score: 0.061
  51. Is Microsatellite Status Associated With Prognosis in Stage II Colon Cancer With High-Risk Features? Dis Colon Rectum. 2021 05; 64(5):545-554.
    View in: PubMed
    Score: 0.060
  52. Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer. Clin Cancer Res. 2021 Oct 15; 27(20):5586-5594.
    View in: PubMed
    Score: 0.060
  53. Improving staging of rectal cancer in the pelvis: the role of PET/MRI. Eur J Nucl Med Mol Imaging. 2021 04; 48(4):1235-1245.
    View in: PubMed
    Score: 0.058
  54. Octogenarians present with a less aggressive phenotype of colon adenocarcinoma. Surgery. 2020 12; 168(6):1138-1143.
    View in: PubMed
    Score: 0.058
  55. Ten-year survival after pathologic complete response in rectal adenocarcinoma. J Surg Oncol. 2021 Jan; 123(1):293-298.
    View in: PubMed
    Score: 0.058
  56. Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer. Clin Colorectal Cancer. 2020 03; 19(1):e8-e17.
    View in: PubMed
    Score: 0.055
  57. Clinical impact of PET/MR in treated colorectal cancer patients. Eur J Nucl Med Mol Imaging. 2019 Oct; 46(11):2260-2269.
    View in: PubMed
    Score: 0.053
  58. Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529. Adv Radiat Oncol. 2017 Apr-Jun; 2(2):110-117.
    View in: PubMed
    Score: 0.045
  59. A pilot study of natural orifice transanal endoscopic total mesorectal excision with laparoscopic assistance for rectal cancer. Surg Endosc. 2013 Sep; 27(9):3396-405.
    View in: PubMed
    Score: 0.034
  60. Update on Transanal NOTES for Rectal Cancer: Transitioning to Human Trials. Minim Invasive Surg. 2012; 2012:287613.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.